Nyxoah
NYXH • NASDAQ
Nyxoah is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Olivier Taelman, with a market cap of $123.1M.
CEOOlivier Taelman
Next Earnings
Upcoming earnings announcement for Nyxoah
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (2:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.56
Revenue Estimate
$7.1M
Earnings History
Past 12 earnings reports for Nyxoah
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | -$0.68Est: -$0.65 | -4.6% | $6.6MEst: $6.7M | -2.5% | — |
| Nov 13, 2025 | Q3 2025 | -$0.74Est: -$0.61 | -21.3% | $2.3MEst: $2.0M | +18.3% | — |
| Aug 18, 2025 | Q2 2025 | -$0.62Est: -$0.63 | +1.6% | $1.5MEst: $1.7M | -12.2% | — |
| May 14, 2025 | Q1 2025 | -$0.63Est: -$0.50 | -25.8% | $1.1MEst: $1.6M | -31.8% | — |
| Mar 13, 2025 | Q4 2024 | -$0.49Est: -$0.47 | -4.3% | $1.3MEst: $2.7M | -49.5% | — |
| Nov 6, 2024 | Q3 2024 | -$0.55Est: -$0.46 | -19.6% | $1.4MEst: $1.5M | -6.0% | — |
| Aug 6, 2024 | Q2 2024 | -$0.46Est: -$0.43 | -7.0% | $830.1KEst: $2.0M | -57.4% | — |
| May 14, 2024 | Q1 2024 | -$0.45Est: -$0.42 | -7.1% | $1.3MEst: $1.3M | +3.6% | — |
| Mar 5, 2024 | Q4 2023 | -$0.41Est: -$0.40 | -2.0% | $2.0MEst: $2.0M | +0.7% | — |
| Nov 8, 2023 | Q3 2023 | -$0.29Est: -$0.45 | +35.6% | $1.1MEst: $1.5M | -27.3% | — |
| Aug 8, 2023 | Q2 2023 | -$0.49Est: -$0.45 | -8.9% | $1.2MEst: $1.1M | +11.8% | — |
| May 16, 2023 | Q1 2023 | -$0.49Est: -$0.36 | -36.1% | $473.3KEst: $1.3M | -63.9% | — |